185 related articles for article (PubMed ID: 9869224)
1. Cervical carcinoma metastatic to para-aortic nodes: extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy: a Gynecologic Oncology Group study.
Varia MA; Bundy BN; Deppe G; Mannel R; Averette HE; Rose PG; Connelly P
Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):1015-23. PubMed ID: 9869224
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy and extended-field radiation therapy to para-aortic area in patients with histologically proven metastatic cervical cancer to para-aortic nodes: a phase II pilot study.
Husseinzadeh N; Shrake P; DeEulis T; Rowley K; Aron B
Gynecol Oncol; 1994 Mar; 52(3):326-31. PubMed ID: 8157190
[TBL] [Abstract][Full Text] [Related]
3. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer.
Morris M; Eifel PJ; Lu J; Grigsby PW; Levenback C; Stevens RE; Rotman M; Gershenson DM; Mutch DG
N Engl J Med; 1999 Apr; 340(15):1137-43. PubMed ID: 10202164
[TBL] [Abstract][Full Text] [Related]
4. Twice-daily fractionation of external irradiation with brachytherapy and chemotherapy in carcinoma of the cervix with positive para-aortic lymph nodes: Phase II study of the Radiation Therapy Oncology Group 92-10.
Grigsby PW; Lu JD; Mutch DG; Kim RY; Eifel PJ
Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):817-22. PubMed ID: 9652843
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study.
Whitney CW; Sause W; Bundy BN; Malfetano JH; Hannigan EV; Fowler WC; Clarke-Pearson DL; Liao SY
J Clin Oncol; 1999 May; 17(5):1339-48. PubMed ID: 10334517
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of RTOG 92-10: cervical cancer with positive para-aortic lymph nodes.
Grigsby PW; Heydon K; Mutch DG; Kim RY; Eifel P
Int J Radiat Oncol Biol Phys; 2001 Nov; 51(4):982-7. PubMed ID: 11704321
[TBL] [Abstract][Full Text] [Related]
7. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma.
Resbeut M; Cowen D; Viens P; Noirclerc M; Perez T; Gouvernet J; Delpero JR; Gamerre M; Boubli L; Houvenaeghel G
Gynecol Oncol; 1994 Jul; 54(1):68-75. PubMed ID: 8020842
[TBL] [Abstract][Full Text] [Related]
8. Hydroxyurea, 5-fluorouracil infusion, and cisplatin adjunct to radiation therapy in cervical carcinoma: a phase I-II trial of the Gynecologic Oncology Group.
Stehman FB; Bundy BN; Kucera PR; Deppe G; Reddy S; O'Connor DM
Gynecol Oncol; 1997 Aug; 66(2):262-7. PubMed ID: 9264574
[TBL] [Abstract][Full Text] [Related]
9. A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: a Gynecologic Oncology Group study.
Walker JL; Morrison A; DiSilvestro P; von Gruenigen VE;
Gynecol Oncol; 2009 Jan; 112(1):78-84. PubMed ID: 19010522
[TBL] [Abstract][Full Text] [Related]
10. Outcome of stage IVA cervical cancer patients with disease limited to the pelvis in the era of chemoradiation: a Gynecologic Oncology Group study.
Rose PG; Ali S; Whitney CW; Lanciano R; Stehman FB
Gynecol Oncol; 2011 Jun; 121(3):542-5. PubMed ID: 21420157
[TBL] [Abstract][Full Text] [Related]
11. Randomized comparison of weekly cisplatin or protracted venous infusion of fluorouracil in combination with pelvic radiation in advanced cervix cancer: a gynecologic oncology group study.
Lanciano R; Calkins A; Bundy BN; Parham G; Lucci JA; Moore DH; Monk BJ; O'Connor DM
J Clin Oncol; 2005 Nov; 23(33):8289-95. PubMed ID: 16230678
[TBL] [Abstract][Full Text] [Related]
12. Extended-field radiotherapy and high-dose-rate brachytherapy with concurrent and adjuvant cisplatin-based chemotherapy for locally advanced cervical cancer: a phase I/II study.
Chung YL; Jian JJ; Cheng SH; Hsieh CI; Tan TD; Chang HJ; Hung CF; Horng CF; Soong T; Tsou MH
Gynecol Oncol; 2005 Apr; 97(1):126-35. PubMed ID: 15790448
[TBL] [Abstract][Full Text] [Related]
13. Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01.
Eifel PJ; Winter K; Morris M; Levenback C; Grigsby PW; Cooper J; Rotman M; Gershenson D; Mutch DG
J Clin Oncol; 2004 Mar; 22(5):872-80. PubMed ID: 14990643
[TBL] [Abstract][Full Text] [Related]
14. Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
Kim YS; Shin SS; Nam JH; Kim YT; Kim YM; Kim JH; Choi EK
Gynecol Oncol; 2008 Jan; 108(1):195-200. PubMed ID: 17963825
[TBL] [Abstract][Full Text] [Related]
15. Cervical cancer: combined modality therapy.
Grigsby PW
Cancer J; 2001; 7 Suppl 1():S47-50. PubMed ID: 11504285
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II study of definitive radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) for advanced or recurrent gynecologic malignancies. Preliminary report.
Kuske RR; Perez CA; Grigsby PW; Lovett RD; Jacobs AJ; Galakatos AE; Camel HM; Kao MS
Am J Clin Oncol; 1989 Dec; 12(6):467-73. PubMed ID: 2686392
[TBL] [Abstract][Full Text] [Related]
17. Phase I-II study of combined 5-fluorouracil and cisplatin chemotherapy and altered fractionation radiotherapy for advanced squamous cell carcinoma of the cervix.
Fishman A; Chiu JK; Girtanner RE; Dennis W; Carpenter LS; Lu HH; Woo SY; Kerley JM; Kaplan AL
Am J Clin Oncol; 1997 Aug; 20(4):342-7. PubMed ID: 9256886
[TBL] [Abstract][Full Text] [Related]
18. [Preoperative concurrent radiation therapy and chemotherapy for operable bulky carcinomas of uterine cervix stages IB2, IIA, and IIB with proximal parametrial invasion].
Lerouge D; Touboul E; Lefranc JP; Uzan S; Jannet D; Moureau-Zabotto L; Genestie C; Antoine M; Jamali M
Cancer Radiother; 2004 Jun; 8(3):168-77. PubMed ID: 15217584
[TBL] [Abstract][Full Text] [Related]
19. Is a low dose of concomitant chemotherapy with extended-field radiotherapy acceptable as an efficient treatment for cervical cancer patients with metastases to the para-aortic lymph nodes?
Kazumoto T; Kato S; Yokota H; Hasumi Y; Kino N; Horie K; Yoshida D; Mizukami T; Saito Y
Int J Gynecol Cancer; 2011 Nov; 21(8):1465-71. PubMed ID: 21892097
[TBL] [Abstract][Full Text] [Related]
20. Prospective phase I/II studies of definitive irradiation and chemotherapy for advanced gynecologic malignancies.
Grigsby PW; Graham MV; Perez CA; Galakatos AE; Camel HM; Kao MS
Am J Clin Oncol; 1996 Feb; 19(1):1-6. PubMed ID: 8554027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
